Emergency Department, Christchurch Hospital, Christchurch, New Zealand.
Christchurch Heart Institute, University of Otago, Christchurch, New Zealand.
Acad Emerg Med. 2018 Apr;25(4):434-443. doi: 10.1111/acem.13343. Epub 2017 Dec 11.
Early discharge of patients with presentations triggering assessment for possible acute coronary syndrome (ACS) is safe when clinical assessment indicates low risk, biomarkers are negative, and electrocardiograms (ECGs) are nonischemic. We hypothesized that the Emergency Department Assessment of Chest Pain Score (EDACS) combined with a single measurement of high-sensitivity cardiac troponin (hs-cTn) could allow early discharge of a clinically meaningful proportion of patients.
We pooled data from four patient cohorts from New Zealand and Australia presenting to an emergency department with symptoms suggestive of ACS. The primary outcome was major adverse cardiac events (MACE) within 30 days of presentation. In patients with a nonischemic ECG we evaluated the sensitivity for MACE and percentage low risk of every combination of high-sensitivity cardiac troponin T (hs-cTnT) concentration and high-sensitivity cardiac troponin I (hs-cTnI) concentration with EDACS. We used a standard smoothing technique on the probability density function for hs-cTn and EDACS and applied bootstrapping to determine the optimal threshold combinations, namely, the combination that maximized the percentage low risk with ≥98.5% sensitivity for MACE.
From 2,536 patients, 2,258 presented without an ischemic ECG of whom 272 (12.1%) had a MACE within 30 days. The optimal threshold for hs-cTnI was 7 ng/L combined with an EDACS threshold of 16 (36.8% patients low risk). The optimal thresholds for hs-cTnT were 8 ng/L combined with an EDACS threshold of 15 (30.2% patients low risk).
Single measurements of both hs-cTnI and hs-cTnT at presentation combined with EDACS to identify over 30% of patients as low risk and therefore eligible for safe early discharge after only one blood draw.
当临床评估显示低风险、生物标志物阴性且心电图(ECG)无缺血时,对于表现出可能的急性冠状动脉综合征(ACS)的患者进行早期出院是安全的。我们假设急诊胸痛评分(EDACS)联合单次高敏心肌肌钙蛋白(hs-cTn)测量可使具有临床意义的比例的患者能够安全提前出院。
我们汇总了来自新西兰和澳大利亚四个患者队列的数据,这些患者因疑似 ACS 的症状就诊于急诊科。主要结局为就诊后 30 天内发生的主要不良心脏事件(MACE)。对于无缺血性 ECG 的患者,我们评估了每一种 hs-cTnT 浓度和 hs-cTnI 浓度与 EDACS 的组合对 MACE 的敏感性和低危风险的百分比。我们使用 hs-cTn 和 EDACS 的概率密度函数的标准平滑技术,并应用自举法确定最佳阈值组合,即最大限度地提高 MACE 敏感性为 98.5%以上的低危风险百分比的组合。
在 2536 例患者中,2258 例患者就诊时无缺血性 ECG,其中 272 例(12.1%)在 30 天内发生 MACE。hs-cTnI 的最佳阈值为 7ng/L,与 EDACS 阈值为 16(36.8%的患者低危)相结合。hs-cTnT 的最佳阈值为 8ng/L,与 EDACS 阈值为 15(30.2%的患者低危)相结合。
在就诊时同时测量 hs-cTnI 和 hs-cTnT,并结合 EDACS,可将 30%以上的患者识别为低危,因此只需进行一次采血即可安全提前出院。